期刊文献+

胰高血糖素肽-1受体激动药对心肌成纤维细胞增殖的影响及其机制研究

Effect and mechanism of glucagon peptide-1 receptor agonist on proliferation in cardiac fibroblasts
原文传递
导出
摘要 目的研究胰高血糖素肽-1受体激动药(Exendin-4)对血管紧张素Ⅱ(AngⅡ)诱导的心肌成纤维化的作用及其机制。方法用Ⅱ型胶原酶消化心脏组织并结合差速贴壁法分离纯化的心肌成纤维细胞(CFb);将CFb分为7组:空白组(无任何处理),模型组(AngⅡ100 nmol·L^-1),阳性对照组(洛沙坦10μmol·L^-1),抑制剂组(U012630μmol·L^-1)和低、中、高3个剂量实验组(Exendin-41,5,10 nmol·L^-1)。四唑盐法检测细胞增殖率;以免疫印迹试验测定细胞CollagenⅠ、磷酸化ERK1/2和磷酸化AKT蛋白的相对表达水平(灰度值)。结果空白组、模型组和低、中、高3个剂量实验组的细胞增殖率分别为(7.31±2.18)%,(30.31±3.88)%,(28.93±2.18)%,(20.17±2.19)%和(17.85±2.36)%;模型组与空白组相比、或者低、中、高3个剂量实验组与模型组相比,差异均有统计学意义(均P<0.01)。空白组、模型组、高剂量实验组和阳性对照组的Collagen I相对表达量分别为0.96±0.08,1.30±0.07,1.01±0.07和0.99±0.05;这4组磷酸化ERK的相对表达量分别为0.52±0.07,1.15±0.26,0.69±0.28和0.64±0.06;这4组的磷酸化AKT的相对表达量分别是0.68±0.18,1.03±0.23,0.70±0.19和0.69±0.18。模型组与空白组相比,差异均有统计学意义(P<0.05或P<0.01);高剂量实验组与模型组相比,差异均有统计学意义(P<0.05或P<0.01)。结论Exendin-4可预防Ang II诱导的心肌纤维化,其作用机制可能通过抑制CFb的增殖、下调ERK和AKT蛋白磷酸化水平,从而减少Collagen I合成来发挥作用的。 Objective To study the preventive effect and possible mechanism of glucagon peptide-1 receptor agonist(Exendin-4)on angiotensinⅡ(AngⅡ)induced myocardial fibrosis.Methods Cardiac tissue was digested with typeⅡcollagenase and separated into purified cardiac fibroblasts(CFb)by differential adherence methods.Cells were divided into seven groups:blank group(without any treatment),model group(AngⅡ100 nmol·L^-1),positive control group(losartan 10μmol·L^-1),inhibitor group(U012630μmol·L^-1),and low,middle,high experimental groups(Exendin-41,5,10 nmol·L^-1).The cell proliferation rate was detected by tetrazolium salt method.The relative expression levels(grey value)of Collagen I,phosphorylated ERK1/2and phosphorylated AKT protein were determined by Western blot.Results The cell proliferation rate in blank group,model group and low,middle,high experimental groups were(7.31±2.18)%,(30.31±3.88)%,(28.93±2.18)%,(20.17±2.19)%,(17.85±2.36)%,respectively;comparing between model group and normal group,the difference was significant(P<0.01);comparing between three doses experimental groups and model group,the difference were significant(all P<0.01).The relative expression levels of Collagen I in blank group,model group,high-dose experimental group,and positive control group were 0.96±0.08,1.30±0.07,1.01±0.07,and0.99±0.05,respectively;the relative expression levels of phosphorylation ERK in the 4 groups were 0.52±0.07,1.15±0.26,0.69±0.28 and 0.64±0.06.The relative expression levels of phosphorylated AKT in the four groups were 0.68±0.18,1.03±0.23,0.70±0.19 and 0.69±0.18,respectively.Comparing between model group and normal group,the difference of the factors were significant(P<0.05 or P<0.01);comparing between experimental group and model group,the difference of the factors were significant(P<0.05 or P<0.01).Conclusion Exendin-4can prevent AngⅡ-induced myocardial fibrosis,and its mechanism may play a role in inhibiting the proliferation of CFb,down-regulating ERK,AKT protein phosphorylation and reducing Collagen I synthesis.
作者 马楠 金红花 MA Nan;JIN Hong-hua(Department of Pharmacy,Yanbian University,Yanji 133002,Jilin Province,China;Department of Pharmacy,Yanbian University Affliated Hospital,Yanji 133002,Jilin Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2020年第3期271-273,共3页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81860077).
关键词 胰高血糖素肽-1受体激动药 心肌成纤维化 血管紧张素Ⅱ 心肌成纤维细胞 洛沙坦 glucagon peptide-1 receptor agonist myocardial fibrosis angiotensinⅡ cardiac fibroblasts losartan
  • 相关文献

参考文献3

二级参考文献39

  • 1刘霞,王常勇.新生大鼠心肌细胞的分离和培养[J].西北农林科技大学学报(自然科学版),2005,33(6):35-39. 被引量:8
  • 2Patella S, Phillips D J, Tchongue J, de Kretser D M, Sievert W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. American Journal of Physiology -Gastrointestinal and Liver Physiology, 2006, 290(1): G137-G144.
  • 3Shiozaki M, Sakai R, Tabuchi M, Nakamura T, Sugino K, Sugino H, Eto Y. Evidence for the participation of endogenous activin Aerythroid differentiation factor in the regulation of erythropoiesis. Proceedings of the National Academy of Sciences, 1992, 89(5): 1553-1556.
  • 4Hashimoto M, Nakamura T, Inoue S, Kondo T, Yamada R, Eto Y, Sugino H, Muramatsu M. Follistatin is a developmentally regulated cytokine in neural differentiation. Journal of Biological Chemistry, 1992, 267(11): 7203-7206.
  • 5Zhu J, Li Y, Lu A, Gharaibeh B, Ma J, Kobayashi T, Quintero A J, Huard J. Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. The American Journal of Pathology, 2011, 179(2): 915-930.
  • 6Gangopadhyay S S. Systemic administration of Follistatin288 increases muscle mass and reduces fat accumulation in mice. Scientific Reports, 2013, 25(11): 541-544.
  • 7Hansen J, Brandt C, Nielsen A R, Hojman P, Whitham M, Febbraio M A, Pedersen B K, Plomgaard P. Exercise induces a marked increase in plasma Follistatin: evidence that Follistatin is a contraction-induced hepatokine. Endocrinology, 2011, 152(1): 164-171.
  • 8Phillips D J, de Kretser D M. Follistatin: a multifunctional regulatory protein. Frontiers in Neuroendocrinology, 1998, 19(4): 287-322.
  • 9Lee S J, Lee Y S, Zimmers T A, Soleimani A, Matzuk M M, Tsuchida K, Cohn R D, Barton E R. Regulation of muscle mass by Follistatin and activins. Molecular Endocrinology, 2010, 24(10): 1998-2008.
  • 10Amthor H, Nicholas G, McKinnell I, Kemp C F, Sharma M, Kambadur R, Patel K. Follistatin complexes Myostatin and anta gonises Myostatin-mediated inhibition of myogenesis. Developmental Biology, 2004, 270(1): 19-30.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部